Stroke is more common than myocardial infarction in hypertension: Analysis based on 11 major randomized intervention trials

被引：79

作者：

Kjeldsen, SE ^{[1
]}

Julius, S

Hedner, T

Hansson, L

机构：

[1] Ullevaal Univ Hosp, Dept Cardiol, NO-0407 Oslo, Norway

[2] Univ Michigan, Med Ctr, Div Hypertens, Ann Arbor, MI USA

[3] Sahlgrens Univ Hosp, Dept Clin Pharmacol, S-41345 Gothenburg, Sweden

[4] Uppsala Univ, Dept Geriatr, Uppsala, Sweden

来源：

BLOOD PRESSURE | 2001年 / 10卷 / 04期

关键词：

D O I：

10.1080/08037050152669684

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

[No abstract available]

引用

页码：190 / 192

页数：3

共 18 条

[1]

[Anonymous], 1991, JAMA, V265, P3255

[2] Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) [J].

Brown, MJ ;

Palmer, CR ;

Castaigne, A ;

de Leeuw, PW ;

Mancia, G ;

Rosenthal, T ;

Ruilope, LM .

LANCET, 2000, 356 (9227) :366-372

[3] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].

COLLINS, R ;

PETO, R ;

MACMAHON, S ;

HEBERT, P ;

FIEBACH, NH ;

EBERLEIN, KA ;

GODWIN, J ;

QIZILBASH, N ;

TAYLOR, JO ;

HENNEKENS, CH .

LANCET, 1990, 335 (8693) :827-838

[4] MORBIDITY AND MORTALITY IN THE SWEDISH TRIAL IN OLD PATIENTS WITH HYPERTENSION (STOP-HYPERTENSION) [J].

DAHLOF, B ;

LINDHOLM, LH ;

HANSSON, L ;

SCHERSTEN, B ;

EKBOM, T ;

WESTER, PO .

LANCET, 1991, 338 (8778) :1281-1285

[5]

Dawber ThomasR., 1980, FRAMINGHAM STUDY EPI

[6]

Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967

[7] Shanghai trial of nifedipine in the elderly (STONE) [J].

Gong, LS ;

Zhang, WZ ;

Zhu, YJ ;

Zhu, JR ;

Kong, DW ;

Page, V ;

Ghadirian, P ;

LeLorier, J ;

Hamet, P .

JOURNAL OF HYPERTENSION, 1996, 14 (10) :1237-1245

[8] Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension:: the Nordic Diltiazem (NORDIL) study [J].

Hansson, L ;

Hedner, T ;

Lund-Johansen, P ;

Kjeldsen, SE ;

Lindholm, LH ;

Syvertsen, JO ;

Lanke, J ;

de Faire, U ;

Dahlöf, B ;

Karlberg, BE .

LANCET, 2000, 356 (9227) :359-365

[9] Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension:: the Captopril Prevention Project (CAPPP) randomised trial [J].

Hansson, L ;

Lindholm, LH ;

Niskanen, L ;

Lanke, J ;

Hedner, T ;

Niklason, A ;

Luomanmäki, K ;

Dahlöf, B ;

de Faire, U ;

Mörlin, C ;

Karlberg, BE ;

Wester, PO ;

Björck, JE .

LANCET, 1999, 353 (9153) :611-616

[10] Randomised trial of old and new antihypertensive drugs in elderly patients:: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study [J].

Hansson, L ;

Lindholm, LH ;

Ekbom, T ;

Dahlöf, B ;

Lanke, J ;

Scherstén, B ;

Wester, PO ;

Hedner, T ;

de Faire, U .

LANCET, 1999, 354 (9192) :1751-1756

← 1 2 →